Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Sitemap: http://www.priovanttx.com/sitemap_index.xml Sitemap: |
Title | Priovant |
Description | Priovant Therapeutics is a clinical-stage biotechnology company developing targeted therapies for patients with severe autoimmune |
Keywords | N/A |
WebSite | priovanttx.com |
Host IP | 35.190.78.10 |
Location | United States |
Site | Rank |
US$6,704,893
Last updated: 2023-05-18 07:47:41
priovanttx.com has Semrush global rank of 1,578,594. priovanttx.com has an estimated worth of US$ 6,704,893, based on its estimated Ads revenue. priovanttx.com receives approximately 773,642 unique visitors each day. Its web server is located in United States, with IP address 35.190.78.10. According to SiteAdvisor, priovanttx.com is safe to visit. |
Purchase/Sale Value | US$6,704,893 |
Daily Ads Revenue | US$6,190 |
Monthly Ads Revenue | US$185,674 |
Yearly Ads Revenue | US$2,228,088 |
Daily Unique Visitors | 51,577 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
priovanttx.com. | A | 3599 | IP: 35.190.78.10 |
priovanttx.com. | A | 3599 | IP: 34.117.3.156 |
priovanttx.com. | NS | 21600 | NS Record: ns2.p10.dynect.net. |
priovanttx.com. | NS | 21600 | NS Record: ns4.p10.dynect.net. |
priovanttx.com. | NS | 21600 | NS Record: ns1.p10.dynect.net. |
priovanttx.com. | NS | 21600 | NS Record: ns3.p10.dynect.net. |
priovanttx.com. | MX | 3600 | MX Record: 0 us-smtp-inbound-1.mimecast.com. |
priovanttx.com. | MX | 3600 | MX Record: 0 us-smtp-inbound-2.mimecast.com. |
priovanttx.com. | TXT | 3600 | TXT Record: google-site-verification=nO-YF5hbLLpk45wfiUMqwQayk55jshsMt0pNYgoaGc8 |
priovanttx.com. | TXT | 3600 | TXT Record: ZOOM_verify_PjVYUgkDUXR79oQtKGwsnz |
priovanttx.com. | TXT | 3600 | TXT Record: MS=ms29842307 |
priovanttx.com. | TXT | 3600 | TXT Record: 0ed1fe018ad4312a8788524766800aa56a77f36791 |
priovanttx.com. | TXT | 3600 | TXT Record: Asana, please add priovanttx.com to Roivant's account |
priovanttx.com. | TXT | 3600 | TXT Record: docusign=86fbb764-5f95-493e-a15a-485e88caa419 |
priovanttx.com. | TXT | 3600 | TXT Record: google-site-verification=3-3nMl6Yww_maSKGwaqJpVZmrCbHD2nUoyX2IAHwV7c |
priovanttx.com. | TXT | 3600 | TXT Record: adobe-idp-site-verification=7b3f0721f0568489314b2dc336bd3139772e94aee97d84bf910d02adf0f4b651 |
priovanttx.com. | TXT | 3600 | TXT Record: atlassian-domain-verification=+6RQoqZNIkiBOw2mOmxo6t+XwDYXj7PrS8CucBHlHEdhymqJ7dX7p/fYZvVAsO/m |
priovanttx.com. | TXT | 3600 | TXT Record: v=spf1 include:us._netblocks.mimecast.com include:spf.protection.outlook.com include:spf.boardbooks.com include:mailsenders.netsuite.com include:servers.mcsv.net include:fsspfus.freshemail.io ~all |
Priovant Therapeutics Priovant Therapeutics Logo About Pipeline Clinical Trials News & Presentations Careers Contact Developing targeted therapies for patients with severe autoimmune disease © 2023 Priovant Therapeutics, Inc. | Privacy Policy | Terms of |
HTTP/1.1 301 Moved Permanently Cache-Control: private Content-Type: text/html; charset=UTF-8 Referrer-Policy: no-referrer Location: https://priovanttx.com:443/ Content-Length: 224 Date: Sat, 28 May 2022 08:52:30 GMT HTTP/2 200 x-guploader-uploadid: ADPycdsqrBeZ5Wj6B3aeosxBoBFEdasiEEMQDzNNG4jFkJYWhF0HxHB61CVeVVOuTV_300PKj75j0wH07OXT6cKWsYQNw-SxolhF date: Sat, 28 May 2022 08:52:30 GMT last-modified: Wed, 09 Mar 2022 16:20:29 GMT etag: "65597bfc62ce25b6c45e245bfe2e2b24" x-goog-generation: 1646842829671144 x-goog-metageneration: 1 x-goog-stored-content-encoding: identity x-goog-stored-content-length: 17896 x-goog-meta-goog-reserved-file-mtime: 1646842824 content-type: text/html x-goog-hash: crc32c=N9FouA== x-goog-hash: md5=ZVl7/GLOJbbEXiRb/i4rJA== x-goog-storage-class: STANDARD accept-ranges: bytes content-length: 17896 server: UploadServer cache-control: public,max-age=,max-age=300 alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000 |
Domain Name: PRIOVANTTX.COM Registry Domain ID: 2643898015_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-09-27T15:39:17Z Creation Date: 2021-09-27T15:39:17Z Registry Expiry Date: 2022-09-27T15:39:17Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.P10.DYNECT.NET Name Server: NS2.P10.DYNECT.NET Name Server: NS3.P10.DYNECT.NET Name Server: NS4.P10.DYNECT.NET Name Server: NS5.DNSMADEEASY.COM Name Server: NS6.DNSMADEEASY.COM Name Server: NS7.DNSMADEEASY.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-28T11:36:54Z <<< |